Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B

  1. de Lecea, M.V. 1
  2. Palomares, T. 2
  3. Al Kassam, D. 3
  4. Cavia, M. 3
  5. Geh, J.L.C. 4
  6. de Llano, P. 3
  7. Muñiz, P. 3
  8. Armesto, D. 3
  9. Martinez-Indart, L. 1
  10. Alonso-Varona, A. 2
  1. 1 Hospital de Cruces
    info

    Hospital de Cruces

    Barakaldo, España

    ROR https://ror.org/03nzegx43

  2. 2 Universidad del País Vasco/Euskal Herriko Unibertsitatea
    info

    Universidad del País Vasco/Euskal Herriko Unibertsitatea

    Lejona, España

    ROR https://ror.org/000xsnr85

  3. 3 Complejo Asistencial Universitario de Burgos
    info

    Complejo Asistencial Universitario de Burgos

    Burgos, España

    ROR https://ror.org/01j5v0d02

  4. 4 Guy's Hospital
    info

    Guy's Hospital

    Londres, Reino Unido

    ROR https://ror.org/04r33pf22

Journal:
Journal of the European Academy of Dermatology and Venereology

ISSN: 1468-3083

Year of publication: 2017

Volume: 31

Issue: 4

Pages: 636-642

Type: Article

DOI: 10.1111/JDV.13968 PMID: 27633490 SCOPUS: 2-s2.0-84995923269 GOOGLE SCHOLAR
Data source: Scopus